Why this small cap biotech has rocketed 2,511% in the last 5 months

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today, taking 5-month returns to a phenomenal 2,585%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today. Zoono has seen very strong share price growth since last September, and particularly since the outbreak of the coronavirus.

The Zoono share price was sitting at just $0.072 in September last year and has since shot all the way up to $1.88 at the time of writing – a phenomenal 2,511% increase.

Zoono is a global biotech company that is involved in the development, manufacture and global distribution of a unique range of long-lasting and environmentally friendly antimicrobial solutions. The company currently has a market capitalization of $307 million.

Following the coronavirus outbreak, Zoono commented that there has been a high interest in Zoono's technology given its proven efficacy against viruses and bacteria, and ability to prevent cross-contamination.

Recently, Zoono reported unaudited revenues for the quarter so far to 10 February 2020 of NZ$2.4 million, with on-line sales in Australia and New Zealand contributing strongly.

a woman

Announcement in response to coronavirus

On 30 January 2020, Zoono announced to the market its confidence of being well-positioned to be part of the solution to both coronavirus and other new virus threats. The company believes that its Zoono technology, particularly its longevity and killing methodology, delivers an ideal solution.

At this time, the company stated that Zoono's Z71 Microbe Shield Surface Sanitiser was successfully tested in 2014 against bovine coronavirus (a surrogate recognised by the World Health Organisation for other members of the coronaviridae family, including the MERS virus). Test results confirmed a 99.99% efficacy in five minutes.

Zoono's Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser products were recently sent to a German laboratory for testing against the latest Chinese strain of the coronavirus (2019-nCoV).

Operationally, once the impact of the new coronavirus emerged, Zoono made an immediate decision in early January to ramp up production of its key active ingredients and its Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser finished goods.

Recent agreement for Chinese childcare & hotel sectors

A week ago, on February 10, Zoono announced it had entered into an exclusive distribution agreement with Beijing Youmeng Technology and Development Limited for the childcare and hotel sectors in China.

At this time, Zoono had received an initial payment of NZD$775,000 from Beijing Youmeng Technology and Development Limited.

Zoono commented that this agreement in the childcare and hotel sectors in China is another step in Zoono's strategy to focus on specific sectors and on the appointment of reputable distributors with explicit expertise in these market segments.

Zoono also pointed out that it has sought to exercise greater control over the activities and performance of its distributors in its new distribution arrangements.

This agreement is the fourth distribution agreement entered into by the company for an industry sector in the Chinese market in the last six months.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »